Quantitative susceptibility mapping in patients with systemic lupus erythematosus: detection of abnormalities in normal-appearing basal ganglia
暂无分享,去创建一个
Tian Liu | Yi Wang | Atsushi Ogasawara | Yukunori Korogi | Yoshiya Tanaka | Keita Watanabe | Shingo Kakeda | Yu Murakami | Yi Wang | Tian Liu | Y. Korogi | Yoshiya Tanaka | S. Ide | S. Kakeda | S. Nakayamada | J. Moriya | Satoru Ide | Issei Ueda | Junji Moriya | Koichiro Futatsuya | Toru Sato | Keita Watanabe | Y. Murakami | I. Ueda | K. Futatsuya | Toru Sato | Kazuyoshi Saito | Shingo Nakayamada | A. Ogasawara | K. Saito
[1] Min Lou,et al. Hematoma Volume Measurement in Gradient Echo MRI Using Quantitative Susceptibility Mapping , 2013, Stroke.
[2] R Marc Lebel,et al. Multiple sclerosis: validation of MR imaging for quantification and detection of iron. , 2013, Radiology.
[3] E. Haacke,et al. Imaging iron stores in the brain using magnetic resonance imaging. , 2005, Magnetic resonance imaging.
[4] Yi Wang,et al. Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: Validation and application to brain imaging , 2010, Magnetic resonance in medicine.
[5] B. Hallgren,et al. THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.
[6] Tian Liu,et al. Internal structures of the globus pallidus in patients with Parkinson’s disease: evaluation with quantitative susceptibility mapping (QSM) , 2015, European Radiology.
[7] Pascal Spincemaille,et al. Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping , 2013, Magnetic resonance in medicine.
[8] Margit Jehna,et al. Quantitative susceptibility mapping in multiple sclerosis. , 2013, Radiology.
[9] E. Haacke,et al. Theory of NMR signal behavior in magnetically inhomogeneous tissues: The static dephasing regime , 1994, Magnetic resonance in medicine.
[10] Torsten Rohlfing,et al. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping , 2011, NeuroImage.
[11] Hellmut Merkle,et al. Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. , 2011, Brain : a journal of neurology.
[12] Simon Hametner,et al. Iron and neurodegeneration in the multiple sclerosis brain , 2013, Annals of neurology.
[13] Mark A. Smith,et al. Mechanisms by which metals promote events connected to neurodegenerative diseases , 2001, Brain Research Bulletin.
[14] Fengchun Zhang,et al. Diagnostic value of single-photon-emission computed tomography in severe central nervous system involvement of systemic lupus erythematosus: a case-control study. , 2005, Arthritis and rheumatism.
[15] O. Meyer,et al. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies. , 1993, Clinical and experimental rheumatology.
[16] Douglas B. Kell,et al. Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples , 2010, Archives of Toxicology.
[17] J. Kang,et al. Systemic lupus erythematosus: brain MR imaging and single-voxel hydrogen 1 MR spectroscopy. , 2000, Radiology.
[18] F. Fazekas,et al. The morphologic correlate of incidental punctate white matter hyperintensities on MR images. , 1991, AJNR. American journal of neuroradiology.
[19] M. Crawford,et al. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. , 1996, The New England journal of medicine.
[20] A. Caprihan,et al. Diffusion tensor imaging in neuropsychiatric systemic lupus erythematosus , 2010, BMC neurology.
[21] Woo Kyung Moon,et al. Comparative evaluation of average glandular dose and breast cancer detection between single-view digital breast tomosynthesis (DBT) plus single-view digital mammography (DM) and two-view DM: correlation with breast thickness and density , 2014, European Radiology.
[22] J. L. Cox,et al. Multimodal imaging in systemic lupus erythematosus patients with diffuse neuropsychiatric involvement , 2013, Lupus.
[23] R. Lisak,et al. Systemic lupus erythematosus: immunopathogenesis of neurologic dysfunction , 2004, Springer Seminars in Immunopathology.
[24] S. Ropele,et al. Quantitative MR imaging of brain iron: a postmortem validation study. , 2010, Radiology.
[25] C. D. Coryell,et al. The Magnetic Properties and Structure of Hemoglobin, Oxyhemoglobin and Carbonmonoxyhemoglobin , 1936, Proceedings of the National Academy of Sciences.
[26] A. Popescu,et al. Neuropsychiatric Systemic Lupus Erythematosus , 2011, Current neuropharmacology.
[27] B. Hart,et al. Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. , 2010, Seminars in arthritis and rheumatism.
[28] A. Stefani,et al. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. , 2010, Brain : a journal of neurology.
[29] S. West,et al. Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. , 1995, The American journal of medicine.
[30] Yi Wang,et al. Quantitative s usceptibility Mapping of Multiple s clerosis lesions at Various ages 1 , 2014 .
[31] S. Packman,et al. T1 hyperintensity in the pulvinar: key imaging feature for diagnosis of Fabry disease. , 2003, AJNR. American journal of neuroradiology.
[32] A. Auvinen,et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. , 2001, Arthritis and rheumatism.
[33] David Pitt,et al. Iron Is a Sensitive Biomarker for Inflammation in Multiple Sclerosis Lesions , 2013, PloS one.
[34] D. Musher,et al. Central nervous system involvement in systemic lupus erythematosus. A study of 150 cases. , 1966, Archives of neurology.
[35] Jeff H. Duyn,et al. Susceptibility contrast in high field MRI of human brain as a function of tissue iron content , 2009, NeuroImage.
[36] C. Zhong,et al. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease. , 2011, Brain : a journal of neurology.
[37] C. Choi,et al. Primary Antiphospholipid Antibody Syndrome: Neuroradiologic Findings in 11 Patients , 2000, Korean journal of radiology.
[38] Yi Wang,et al. A novel background field removal method for MRI using projection onto dipole fields (PDF) , 2011, NMR in biomedicine.
[39] Yi Wang,et al. Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map , 2012, NeuroImage.
[40] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[41] D. Sackett,et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.
[42] S. Lee,et al. The efficacy of brain 18 F-fluorodeoxyglucose positron emission tomography in neuropsychiatric lupus patients with normal brain magnetic resonance imaging findings , 2012, Lupus.